-
Biotech, A.I. Companies Model Animal Studies/Clinical Trials
A discoverer of neuroscience therapies and a genomics data science company are developing machine learning models to predict clinical trial outcomes for ADHD drugs.
-
Why Technology is Needed in Modern Business
It’s crucial for business owners to know much more about technology than they probably do right now, so they can use it to their advantage and create a business that can really be something special.
-
Trial Underway Testing Stem Cell Particles for Burns
A clinical trial has begun testing an experimental treatment for burns using off-the-shelf therapeutic particles derived from human bone marrow stem cells.
-
Advanced Encryption Shown to Enable Cancer Data Sharing
Data scientists and cancer specialists demonstrate a data encryption technique that makes possible real-world cancer data sharing while preserving individual privacy.
-
Industry, Univ. Labs Partner on Parkinson’s Digital Biomarkers
A developer of electronic health data tools and a university’s neuroscience labs are collaborating on tests of Parkinson’s disease drugs using digital measures of patient functioning.
-
Infographic – Some Good Corporate Venture Fund News
Since the start of 2021, most news has been gloomy about venture investments, but a report last week suggests corporate venture capital funding worldwide is picking up.
-
Health App Shown to Improve Asthma, Depression Outcomes
Findings from two clinical trials show a digital health mobile app helps improve outcomes and manage the conditions for people with depression and asthma.
-
Regeneron Acquires Hearing Loss Biotech in $213M Deal
Regeneron Pharmaceuticals, a maker of synthetic biologic treatments, is acquiring Decibel Therapeutics, developer of gene therapies to treat hearing loss and balance disorders.
-
Companies to Assess Ovarian Health Biotech Drug
A women’s health biotechnology company is partnering with a Brazilian drug maker to evaluate a precision target and treatment for ovarian health disorders.
-
Trial Shows Vaccine Induces Chikungunya Immune Response
Initial findings from a large clinical trial testing a vaccine against the chikungunya virus show the vaccine generates protective antibodies in the vast majority of recipients.